- Filed
- Feb 14, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Feb 14, 2024 | 11.78M sh |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $5.25M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $8.15M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $951.07K |
| Current Liabilities | Q2 2024 · Jun 30, 2023 | $534.25K |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $951.07K |
| Total Liabilities | Q2 2024 · Jun 30, 2023 | $2.03M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $5.32M |
| Current Assets | Q2 2024 · Jun 30, 2023 | $8.45M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $13.4M |
| Total Assets | Q2 2024 · Jun 30, 2023 | $16.9M |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 11.61M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 11.6M sh |
| Capex | Q2 2024 · Dec 31, 2022 | $89.85K |
| Operating Cash Flow | Q2 2024 · Dec 31, 2022 | −$2.43M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $19.87M |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | $21.56M |
| Stockholders Equity | Q2 2024 · Jun 30, 2022 | $23.08M |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | −$0.15 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | −$0.29 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | −$0.15 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | −$0.29 |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $663.28K |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $1.17M |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $1.17M |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $2.28M |
| Net Income | Q2 2024 · Dec 31, 2022 | −$1.75M |
| Net Income | Q2 2024 · Dec 31, 2022 | −$3.32M |
| Net Income | Q2 2024 · Sep 30, 2022 | −$1.57M |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$1.83M |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$3.46M |